# Suitability of 11C-ORM-13070 as a PET Tracer

> **NCT00735774** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 11C-ORM-13070

## Key facts

- **NCT ID:** NCT00735774
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735774, "Suitability of 11C-ORM-13070 as a PET Tracer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00735774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*